Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T helper type 17 cells (Th17) are a distinct subset of CD4+ T helper lymphocytes characterized by their production of interleukin-17 (IL-17), particularly IL-17A and IL-17F. Th17 cells are pro-inflammatory and play a crucial role in host defense against extracellular pathogens, especially at mucosal and epithelial barriers. They are developmentally distinct from the classical Th1 and Th2 lineages, with unique differentiation pathways and effector functions. Dysregulation of Th17 cells can lead to tissue-damaging inflammation seen in many autoimmune/inflammatory disorders.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T helper type 17 cell (Th17).